News

The 2010 Working Group on New TB Drugs Annual Meeting


4 Oct 2010
by Working Group

Working Group on New TB Drugs Annual Meeting

Working Group on New TB Drugs Annual Meeting

The 2010 Annual Meeting will be held on November 12, 2010

Please check this page for continuously updated information.

The WGND will host our annual meeting prior to the start of the 41st Union World Conference on Lung Health (The Union) in Berlin.

WHEN: Friday, November 12, 2010, 7:30am – 1:00pm

WHERE: The Kempinski Hotel Bristol Berlin, http://www.kempinski-berlin.de/en/hotel/

WHY: Review progress of drugs in the Global Pipeline, review WGND 2010 activities, propose and discuss 2011 objectives, and network.

Draft Agenda

*Note: this agenda will always reflect the latest available information. Please check back for updates.

7:30- 8:15 Buffet breakfast and networking

8:15-8:25 Welcome, 2010 Recap

Mel Spigelman/Bill Bishai, Co-Chairs

Co-Chairs will welcome members and introduce agenda for the meeting

8:25-8:35 WGND Website: state-of-the pipeline, blog, resources, grants finder

John Michael Maas, Darby Communications and Lisan Parker, Secretariat

8:35-8:45 WGND Community Representatives: Who we are, What we do, and Why we do it

Albert Makone, WGND Community Representatives

8:45-9:00 GSK-Open Source TB Drug Discovery talk

Martin Pan, Discovery Medicine, Diseases of the Developing World Medicines Development Campus, GlaxoSmithKline R&D

9:00-9:15 NIAID’s new TB R&D initiatives

Christine Sizemore

9:15-9:30 Stop TB Global Plan Revision- New Drugs specifics

Christian Lienhardt, Stop TB Partnership Secretariat, Clinical Trial Capacity Subgroup

9:30-9:45 Coffee Break and networking

9:45-11:15 Roundtable update of major clinical programs

Panel discussion to provide 5-10 min updates on drug progress (consisting of invited speakers from all of the companies conducting clinical trials)

Including:

PNU-100480

SQ109

AZD5847

PA-824

TMC-207

Rifapentine

Linezolid

Gatifloxacin

Moxifloxacin

11:15-12:15 ‘Working’ Lunch (buffet) Subgroup Workshop/Breakout sessions

Subgroups convene to discuss implementation strategies and 2011 initiatives

12:15-12:40 Recap Subgroup Workshop/Breakout sessions

Subgroup leaders present 5 min summary of breakout session discussion

12:40-12:50 Meeting Summary and Adjournment

Mel Spigelman/Bill Bishai, Co-Chairs

1:00pm Shuttle from Kempinski hotel to ICC

More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...